Authors

Philip Sclafani
Megan Wetzel
Latest Article

Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending

In the second part of her Pharma Commerce video interview Megan Wetzel, VP, product, access & affordability at CoverMyMeds, describes how high development costs, personalized treatment models, and an aging population are intensifying the imbalance.

Nicholas Saraceno, Editor

Nicholas Saraceno is Editor of Pharmaceutical Commerce. He can be reached at [email protected].

Latest Article

BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal

The acquisition brings together two leaders in mRNA innovation, strengthening BioNTech’s oncology strategy and expanding its R&D and commercialization capabilities.

Partha Anbil
Latest Article

Empowering Patients as Partners: The Next Frontier for Pharma Companies

Life sciences organizations have an opportunity to move beyond patient-centered care and embrace a model that values lived experience, fosters collaboration, and positions patients as active contributors to research, treatment, and innovation.

Akshay Kapadia
Latest Article

Modernizing GxP Compliance in Life Sciences: The Role of Digital Tools and Validation Expertise

In an era of increasing regulatory complexity, life sciences organizations are modernizing GxP compliance through digital tools like eQMS, cloud platforms, and automated validation, while expert validation services remain essential for aligning these technologies with real-world workflows and inspection readiness.

Rachel Thorpe, MBA, Otsuka Patient Assistance Foundation

Executive Director of the Otsuka Patient Assistance Foundation, Inc. (OPAF)

Latest Article

Changing the PAP Model

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

Allen Putman
Latest Article

Beyond the Brand Team: Why Every Employee Needs to Be Part of the Journey

Engaging the full workforce—from HR to R&D—can elevate launch outcomes, build trust, and create long-term brand ambassadors.

Jen Butler
Latest Article

The Hidden Costs of Prior Authorizations and Patient Loneliness

Administrative hurdles and emotional isolation are driving therapy abandonment and worsening outcomes—Megan Wetzel of CoverMyMeds and Jen Butler of Pleio say the solution lies in combining streamlined access with stronger human connection.

Nick Downey, DGeo
Latest Article

Greener, Smarter, and Less Expensive: How Pharma Packaging is Evolving

As the sentiment of surveyed dangerous goods experts backs up, updated packaging pursuits can boost efficiency and cut costs—while mitigating the environmental impact.

Scott Snyder, PhD
Latest Article

Measuring What Matters

Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.

Martha Kirkpatrick
Latest Article

From Aisles to Access: How Grocery-Based Pharmacies are Evolving into Community Health Hubs

Amid the growing crisis of pharmacy deserts, these entities are tapping new avenues in care delivery, including the integration of clinical services, nutrition counseling, and real-time patient education.

Linda Malek, JD
Latest Article

How Healthcare Organizations Can Balance Federal and State AI Regulations

In the third part of her Pharma Commerce video interview, Linda Malek, JD, partner at Crowell & Moring, explains how healthcare organizations can harmonize both approaches by prioritizing fairness, transparency, and adaptable systems.

Thani Jambulingam, PhD

A professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business.

Latest Article

Bolstering Health Technology Assessment With the Help of AI

Ways to address limitations while also enhancing the decision-making process.

Ilya Preston, PAXAFE

CEO of PAXAFE.

Latest Article

Reducing Risk in the Pharmaceutical Cold Chain

When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.

Ammie McAsey
Latest Article

LogiPharma USA 2025: Advanced Therapies Push Pharma Supply Chains Beyond Speed

As precision medicine reshapes drug distribution, Ammie McAsey, SVP of Supply Chain Operations, McKesson, highlights the need for deeper investments in technology, temperature control, and end-to-end visibility to ensure quality and patient safety in advanced therapy supply chains.

Chris Dowd, ConnectiveRx

Senior Vice President, Market Development, at ConnectiveRx.

Latest Article

Hubs as Revenue Protection: Rethinking Patient Access in the Era of Disruption

Amid intensified competition—and evolving IRA and PBM dynamics—leaders in the access space must now adopt a strategist mindset.

ABM Life Sciences
Latest Article

Your Trusted Resource for Mission Critical Solutions

There’s a reason your facility’s most sensitive operations are called “mission critical.” Learn how ABM’s highly technical management services can take the worry out of maintaining your most specialized systems.

Grundfos
Latest Article

Machine Health in Pharmaceutical Production

Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.

Shweta Maniar, Google Cloud

Director of Global Healthcare & Life Sciences Industry Strategy at Google Cloud.

Latest Article

Beyond the Hype: GenAI’s Real Impact on Life Sciences Manufacturing

Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.

Ammie McAsey, McKesson

SVP of Customer Distribution Experience at McKesson. She leads the company’s distribution strategy across the US for brand, generic, and specialty pharmaceuticals.

Latest Article

Strategies to Modernize, Future-Proof, and Secure the Healthcare Supply Chain

Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.

Angie Franks, Kalderos
Latest Article

340B Litigation and the Path Toward Transparent Drug Discount Programs

As pharma drug pricing debates heat up, the 340B program faces mounting challenges from outdated regulations, duplicate discounts, and limited transparency.

SamaCare
Latest Article

How One Brand Protected Market Share Amid Biosimilar Pressure

Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.

Kamini Anbil
Latest Article

Multi-Indication Drug Branding in Today’s Pharmaceutical Industry

As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.

Matthew Sample
Latest Article

Understanding the FDA's Exemption for DSCSA Compliance

In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us